TCI Wealth Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-21
Closed -$1.77K 817
2023
Q1
$1.77K Hold
21
﹤0.01% 1994
2022
Q4
$1.71K Sell
21
-3
-13% -$242 ﹤0.01% 2010
2022
Q3
$2K Buy
24
+6
+33% +$539 ﹤0.01% 1921
2022
Q2
$2K Sell
18
-3
-14% -$311 ﹤0.01% 1986
2022
Q1
$3K Hold
21
﹤0.01% 1869
2021
Q4
$3K Hold
21
﹤0.01% 1993
2021
Q3
$2K Sell
21
-62
-75% -$6.84K ﹤0.01% 2110
2021
Q2
$10K Buy
83
+7
+9% +$840 ﹤0.01% 951
2021
Q1
$8K Buy
76
+44
+138% +$4.78K ﹤0.01% 972
2020
Q4
$3K Hold
32
﹤0.01% 1076
2020
Q3
$2K Sell
32
-19
-37% -$1.43K ﹤0.01% 1098
2020
Q2
$4K Sell
51
-68
-57% -$4.28K ﹤0.01% 790
2020
Q1
$6K Buy
119
+94
+376% +$6.04K ﹤0.01% 665
2019
Q4
$2K Buy
+25
New +$1.92K ﹤0.01% 1131
2019
Q3
Sell
-6
Closed 1520
2019
Q2
$0 Buy
+6
New +$456 ﹤0.01% 1454
2019
Q1
Sell
-5
Closed 1440
2018
Q4
$0 Buy
5
+2
+67% +$159 ﹤0.01% 1489
2018
Q3
$0 Sell
3
-36
-92% -$3.57K ﹤0.01% 1491
2018
Q2
$4K Buy
+39
New +$4.12K ﹤0.01% 835
2016
Q2
Sell
-155
Closed -$11K 1313
2016
Q1
$11K Buy
+155
New +$10.2K 0.01% 556

Other funds holding EMN

TCI Wealth Advisors's EMN Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Eastman Chemical (EMN) in Q2 2023, closing a stake of 21 shares — an estimated $1.77K sold.

TCI Wealth Advisors first reported a position in EMN in Q1 2016 and held it in 19 quarters. The position peaked at $11K in Q1 2016. 693 funds tracked by Wall St. Rank hold EMN as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Eastman Chemical position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 21 Eastman Chemical shares in Q2 2023, an estimated $1.77K.
  • TCI Wealth Advisors first reported a position in Eastman Chemical in Q1 2016 and held it in 19 quarters.
  • TCI Wealth Advisors's Eastman Chemical position peaked at $11K in Q1 2016.
  • 693 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.